CareDx, Inc. CDNA
Set alert
At close · Oct 30
After hours · Oct 30, 5:53 PM ET
- YTD
- +363.96%
- 1 year
- +504.08%
- Open
- 82.10
- Prev close
- 71.52
- Mkt cap
- 4.52B
- Vol
- 3.55M
- Avg vol
- 1.29M
- EPS
- 2.08
- P/E
- 42.02
- Div yield
- 0.00%
More statistics
- Low
- 81.22
- High
- 90.87
- Forward P/E
- 67.76
- Beta
- 2.38
- Short ratio
- 4.56
- Inst. own
- 102.90%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 23, 2027
- 50-d avg
- 59.12
- 200-d avg
- 33.31
- 1y target
- 65.33
5D chart
Events in this range
- Oct 27, 2026Rating: BTIG · Buy → Buy
- Oct 29, 2026Earnings: 0.7; estimate 0.2548; surprise 174.73%
- Oct 30, 2026Rating: BTIG · Buy → Buy
Signals (119)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:20 PM | 1 day ago |
| SMA: Bullish | Oct 30, 3:20 PM | 1 day ago |
| SMA: Bearish | Oct 30, 3:15 PM | 1 day ago |
| SMA: Bullish | Oct 30, 3:00 PM | 1 day ago |
| SMA: Bearish | Oct 30, 2:45 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 2:35 PM | 1 day ago |
| SMA: Bullish | Oct 30, 2:25 PM | 1 day ago |
| SMA: Bearish | Oct 30, 2:05 PM | 1 day ago |
| SMA: Bullish | Oct 30, 2:00 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:30 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:25 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:30 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:30 PM | 1 day ago |
| SMA: Bullish | Oct 30, 12:10 PM | 1 day ago |
| SMA: Bullish | Oct 30, 12:10 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:00 PM | 1 day ago |
| SMA: Bearish | Oct 30, 11:55 AM | 1 day ago |
| SMA: Bullish | Oct 30, 11:35 AM | 1 day ago |
| SMA: Bearish | Oct 30, 11:25 AM | 1 day ago |
| SMA: Bullish | Oct 30, 11:10 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:55 AM | 1 day ago |
| SMA: Bullish | Oct 30, 10:45 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 10:40 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:30 AM | 1 day ago |
| SMA: Bullish | Oct 30, 10:25 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:15 AM | 1 day ago |
| SMA: Bullish | Oct 30, 9:30 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 9:30 AM | 1 day ago |
| RSI: Overbought | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bullish | Oct 29, 3:50 PM | 2 days ago |
| RSI: Oversold | Oct 29, 3:20 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:55 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 2:55 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:45 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:15 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:05 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:05 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:30 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 1:15 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:00 PM | 2 days ago |
| SMA: Bearish | Oct 29, 11:50 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:35 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 11:10 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:05 AM | 2 days ago |
| RSI: Oversold | Oct 29, 10:55 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:55 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:55 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 9:55 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 9:50 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:45 AM | 2 days ago |
| RSI: Oversold | Oct 29, 9:35 AM | 2 days ago |
| SMA: Bearish | Oct 28, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:45 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:25 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:05 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:45 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:40 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:00 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 1:00 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:05 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:05 PM | 3 days ago |
| SMA: Bullish | Oct 28, 11:50 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:15 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:05 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:35 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 9:35 AM | 3 days ago |
| RSI: Oversold | Oct 27, 3:50 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:45 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:40 PM | 4 days ago |
| RSI: Oversold | Oct 27, 3:35 PM | 4 days ago |
| RSI: Oversold | Oct 27, 3:10 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:25 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:20 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 2:15 PM | 4 days ago |
| RSI: Overbought | Oct 27, 1:35 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:20 PM | 4 days ago |
| RSI: Overbought | Oct 27, 1:15 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:00 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:55 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:20 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:15 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:05 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:00 PM | 4 days ago |
| SMA: Bullish | Oct 27, 11:55 AM | 4 days ago |
| SMA: Bearish | Oct 27, 11:45 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 11:40 AM | 4 days ago |
| RSI: Overbought | Oct 27, 11:30 AM | 4 days ago |
| RSI: Overbought | Oct 27, 11:10 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:40 AM | 4 days ago |
| RSI: Overbought | Oct 27, 10:40 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:35 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:30 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:25 AM | 4 days ago |
| RSI: Overbought | Oct 27, 10:20 AM | 4 days ago |
| RSI: Overbought | Oct 27, 9:35 AM | 4 days ago |
| SMA: Bullish | Oct 26, 3:25 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:20 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:05 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:45 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:40 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 2:40 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:25 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:20 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:25 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:10 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:55 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:50 PM | 5 days ago |
| SMA: Bearish | Oct 26, 11:40 AM | 5 days ago |
| SMA: Bullish | Oct 26, 10:20 AM | 5 days ago |
News
1 day ago fool.com
Why CareDx Stock Soared Today
CareDx is a leader in the fast-growing field of medical diagnostics. The company is working to bring its non-invasive tests to new markets.
1 day ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers CareDx (NASDAQ:CDNA) shares rose 22.2% to $87.42 during Friday's regular session. The company's market cap stands at $3.7 billion. As per the press release, Q3 earnings came out yesterday.…
1 day ago benzinga.com
AutoNation, Regeneron Pharmaceuticals, AstraZeneca And Other Big Stocks Moving Higher On Friday
U.S. stocks fell Friday, but AutoNation jumped 8% after beating Q3 estimates; OneSpan, Grid Dynamics and others posted double-digit gains.
1 day ago seekingalpha.com
CareDx, Inc. (CDNA) Q3 2026 Earnings Call Transcript
CareDx, Inc. (CDNA) Q3 2026 Earnings Call Transcript
1 day ago benzinga.com
Why Civeo Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
Civeo shares surged 19.9% after earnings beat estimates and FY2026 sales guidance rose; other premarket movers included SLGB, HUBC and ATEC.
2 days ago marketbeat.com
What CareDx (CDNA) Said on Its Q3 Earnings Call
CareDx NASDAQ: CDNA reported third-quarter 2026 revenue growth of 39% as testing volumes increased, driven by its transplant business and the addition of Specialty Oncology testing following the July…
2 days ago zacks.com
CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates
CareDx (CDNA) came out with quarterly earnings of $0.7 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.28 per share a year ago.
2 days ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 16.1% to $0.92 during Thursday's after-market session. The company's market cap stands at $2.2 million. CareDx (NASDAQ:CDNA) stock rose 15.0% to…
-
2 days ago benzinga.com
CareDx Raises FY2026 Sales Guidance from $490.000M-$500.000M to $520.000M-$530.000M vs $489.692M Est
CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $490.000 million-$500.000 million to $520.000 million-$530.000 million vs $489.692 million estimate.
-
2 days ago benzinga.com
CareDx Q3 Adj. EPS $0.70 Beats $0.25 Estimate, Sales $139.362M Beat $120.608M Estimate
CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.25 by 180 percent. This is a 150 percent increase over earnings of $0.28 per share…
2 days ago businesswire.com
CareDx Announces Third Quarter 2026 Financial Results
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today reported financial results…
5 days ago zacks.com
CareDx to Report Q3 Earnings: Transplant Testing Growth in Focus
CareDx's Q3 earnings are in focus as transplant testing growth, stronger reimbursement and oncology expansion drive revenue prospects despite potential margin pressures.
1 week ago businesswire.com
CareDx Announces New KOAR Data Linking Elevated AlloSure® Kidney to Nearly 3-Fold Higher Risk of Adverse Graft Outcomes in Patients with Borderline Rejection or TCMR at ASN Kidney Week 2026
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today highlighted data featuring…
-
1 week ago benzinga.com
Canaccord Genuity Maintains Buy on CareDx, Raises Price Target to $80
Canaccord Genuity analyst Kyle Mikson maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $65 to $80.
2 weeks ago gurufocus.com
CareDx Inc (CDNA) Shares Fall 4.0% -- GF Value Says Still Overvalued
On October 16, 2026, CareDx Inc (CDNA) shares fell 4.0% to $64.00, reflecting a volatile performance over the past year, with a 52-week high of $72.51 and a low
2 weeks ago businesswire.com
CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced it will report…
3 weeks ago benzinga.com
Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up
Cathie Wood's ARK dumps $18M of Twist Bioscience while buying Recursion, Veracyte and Intellia, extending its CRISPR bet to 50 sessions.
3 weeks ago defenseworld.net
Critical Contrast: CollPlant Biotechnologies (NASDAQ:CLGN) & CareDx (NASDAQ:CDNA)
CareDx (NASDAQ: CDNA - Get Free Report) and CollPlant Biotechnologies (NASDAQ: CLGN - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two…
1 month ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
1 month ago zacks.com
CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar?
CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the…
1 month ago benzinga.com
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
The Centers for Medicare & Medicaid Services plans to align its 2027 clinical laboratory fee schedule rates with private sector payer rates, aiming to curb excessive Medicare payments and save…
1 month ago benzinga.com
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.
1 month ago zacks.com
5 Top-Ranked High-Efficiency Stocks With Strong Profit Potential
Five stocks stand out for high efficiency, with strong receivables, asset, inventory and operating margin metrics.
1 month ago defenseworld.net
CareDx (NASDAQ:CDNA) Hits New 1-Year High – Time to Buy?
CareDx, Inc. (NASDAQ: CDNA - Get Free Report)'s share price reached a new 52-week high on Monday. The stock traded as high as $55.21 and last traded at $53.7380, with a volume of 1203 shares. The…
1 month ago zacks.com
4 Healthcare Stocks to Play Safe as Fed Gears Up for Rate Hike
AMGN, BHC, CDNA and CNC offer defensive healthcare plays as inflation climbs and the Fed readies for a possible rate hike.
1 month ago zacks.com
Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks
COCO, CHEF, ASMB and CDNA stand out as four defensive picks amid volatility induced by rising oil prices and Middle East tensions.
1 month ago zacks.com
Are Medical Stocks Lagging CareDx (CDNA) This Year?
Here is how CareDx (CDNA) and Concentra Group (CON) have performed compared to their sector so far this year.
-
1 month ago benzinga.com
Canaccord Genuity Initiates Coverage On CareDx with Buy Rating, Announces Price Target of $65
Canaccord Genuity analyst Kyle Mikson initiates coverage on CareDx (NASDAQ:CDNA) with a Buy rating and announces Price Target of $65.
2 months ago defenseworld.net
Canada Pension Plan Investment Board Takes Position in CareDx, Inc. $CDNA
Canada Pension Plan Investment Board purchased a new position in shares of CareDx, Inc. (NASDAQ: CDNA) in the second quarter, according to the company in its most recent disclosure with the SEC. The…
2 months ago zacks.com
CareDx (CDNA) is a Great Momentum Stock: Should You Buy?
Does CareDx (CDNA) have what it takes to be a top stock pick for momentum investors? Let's find out.
2 months ago defenseworld.net
Bamco Inc. NY Makes New $55.21 Million Investment in CareDx, Inc. $CDNA
Bamco Inc. NY bought a new stake in CareDx, Inc. (NASDAQ: CDNA) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional…
2 months ago benzinga.com
CNH Industrial Posts Upbeat Q2 Earnings, Joins Autolus Therapeutics, Bowhead Specialty Holdings And Other Big Stocks Moving Higher On Monday
Dow Jones index gained 600 points, CNH Industrial rose 16% after reporting better-than-expected Q2 results, other stocks also recording gains.
3 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Replimune Group (NASDAQ:REPL) stock rose 96.1% to $10.61 during Friday's regular session. SCYNEXIS (NASDAQ:SCYX) stock moved upwards by 22.54% to $4.57. The market value of their outstanding…
-
3 months ago benzinga.com
HC Wainwright & Co. Reiterates Neutral on CareDx, Maintains $46 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral and maintains $46 price target.
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Scribe Therapeutics (NASDAQ:SCTX) shares increased by 12.7% to $23.0 during Thursday's after-market session. The market value of their outstanding shares is at $297.1 million. uniQure…
-
3 months ago benzinga.com
CareDx Q2 Adj. EPS $0.37 Beats $0.23 Estimate, Sales $131.948M Beat $114.044M Estimate
CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.23 by 60.87 percent. This is a 270 percent increase over earnings of $0.10 per…
-
3 months ago benzinga.com
CareDx Raises FY2026 Sales Guidance from $447.000M-$465.000M to $490.000M-$500.000M vs $455.924M Est
CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $447.000 million-$465.000 million to $490.000 million-$500.000 million vs $455.924 million estimate.
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's regular session. The company's market cap stands at $7.6 million. Agape ATP (NASDAQ:ATPC) shares moved…
3 months ago benzinga.com
Abbott Laboratories, AtaiBeckley, ManpowerGroup And Other Big Stocks Moving Higher On Thursday
U.S. stocks mixed, Nasdaq falls 150 points. Abbott Labs beats Q2 estimates and raises guidance, stock jumps 12.1%. Other big gainers include ATAI, MAN, DSGR, CDNA, MAAS, HELP, RHI, SMG, FWRD, UNH,…
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
6 months ago benzinga.com
Earnings Scheduled For April 28, 2026
Earnings Scheduled For April 28, 2026
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
6 months ago benzinga.com
Aehr Test Systems, CareDx, Okta And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed on Thursday, with the Dow Jones gaining 0.1%. Aehr Test Systems shares rose 15.6% following a $41M production order from an AI customer. Other big gainers include Xanadu…
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
8 months ago benzinga.com
Earnings Scheduled For February 24, 2026
Earnings Scheduled For February 24, 2026
-
12 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 months ago benzinga.com
Earnings Scheduled For November 4, 2025
Earnings Scheduled For November 4, 2025
1 year ago benzinga.com
This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday